Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Next Science Ltd (NXSCF)
OTHER OTC:NXSCF
Next Science Ltd (NXSCF) Stock Price & Analysis
7 Followers
NXSCF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.11 - $0.51
Previous Close$0.26
Volume10.00K
Average Volume (3M)9.76K
Market Cap
$87.96M
Enterprise Value$84.07M
Total Cash (Recent Filing)$5.11M
Total Debt (Recent Filing)$1.22M
Price to Earnings (P/E)-3.7
Beta0.71
Next Earnings
Aug 28, 2024EPS Estimate
-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares OutstandingN/A
10 Day Avg. Volume1,273
30 Day Avg. Volume9,764
Standard Deviation0.18
R-Squared0.23
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit9.19
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.24Price Target Upside-7.69% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Next Science Ltd News
PremiumCompany Announcements
Next Science Targets $12.5bn Healthcare Opportunity
PremiumCompany Announcements
Next Science Optimizes Sales Strategy for Growth
PremiumCompany Announcements
Next Science’s Surgical Solution Shows Promise
PremiumCompany Announcements
Next Science’s Breakthrough in Infection PreventionPremiumCompany Announcements
Next Science’s XPERIENCE™ Proves Effective in SurgeryPremiumCompany Announcements
Next Science’s BLASTX™ Boosts Wound Therapy EfficacyPremiumCompany Announcements
Next Science Ltd Emphasizes Strong Governance
PremiumCompany Announcements
Next Science Releases 2023 Annual ReportOptions Prices
Currently, No data available
---
Ownership Overview
3.33% Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
96.67% Public Companies and
Individual Investors
NXSCF FAQ
What was Next Science Ltd’s price range in the past 12 months?
Next Science Ltd lowest stock price was $0.10 and its highest was $0.51 in the past 12 months.
What is Next Science Ltd’s market cap?
Currently, no data Available
When is Next Science Ltd’s upcoming earnings report date?
Next Science Ltd’s upcoming earnings report date is Aug 28, 2024 which is in 118 days.
How were Next Science Ltd’s earnings last quarter?
Next Science Ltd released its earnings results on Feb 27, 2024. The company reported -$0.021 earnings per share for the quarter, beating the consensus estimate of -$0.026 by $0.005.
Is Next Science Ltd overvalued?
According to Wall Street analysts Next Science Ltd’s price is currently Overvalued.
Does Next Science Ltd pay dividends?
Next Science Ltd does not currently pay dividends.
What is Next Science Ltd’s EPS estimate?
Next Science Ltd’s EPS estimate is -$0.01.
How many shares outstanding does Next Science Ltd have?
Next Science Ltd has 291,695,100 shares outstanding.
What happened to Next Science Ltd’s price movement after its last earnings report?
Next Science Ltd reported an EPS of -$0.021 in its last earnings report, beating expectations of -$0.026. Following the earnings report the stock price went down -16.667%.
Which hedge fund is a major shareholder of Next Science Ltd?
Currently, no hedge funds are holding shares in NXSCF
---
Next Science Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.24 (-7.69% Downside)
$0.24 (-7.69% Downside)
Blogger Sentiment
Bullish
NXSCF Sentiment 92%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.43%
12-Months-Change
Fundamentals
Return on Equity
-156.02%
Trailing 12-Months
Asset Growth
43.67%
Trailing 12-Months
Company Description
Next Science Ltd
Next Science Ltd is an Australia based company formed to commercialise and develop its Xbio technology, which is a non-toxic technology with efficacy in eradicating both biofilm based and free-floating bacteria. The company's products includes SurgX Sterile wound Gel, Bactisure Surgical Lavage and Blast X Wound Gel.
---
NXSCF Stock 12 Months Forecast
Average Price Target
$0.24
▼(-7.69% Downside)
Technical Analysis
Best Analysts Covering NXSCF
1 Year
1 Year Success Rate
3/8 ratings generated profit
1 Year Average Return
-19.06%
reiterated a buy rating 2 months ago
Copying Elyse Shapiro's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -19.06% per trade.
---